Published in Phys Med Biol on May 07, 2002
Scatter modelling and compensation in emission tomography. Eur J Nucl Med Mol Imaging (2004) 1.62
Novel scatter compensation of list-mode PET data using spatial and energy dependent corrections. IEEE Trans Med Imaging (2010) 0.77
Applicability of emission-based attenuation map for rapid CBF, OEF, and CMRO2 measurements using gaseous (15)O-labeled compounds. EJNMMI Phys (2015) 0.76
Validation of a simplified scatter correction method for 3D brain PET with (15)O. Ann Nucl Med (2016) 0.75
GATE: a simulation toolkit for PET and SPECT. Phys Med Biol (2004) 7.88
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62
Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol (2011) 3.14
Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry (1991) 2.89
Concept of reaction volume in the in vivo ligand-receptor model. J Nucl Med (1996) 2.01
Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Neurology (1995) 1.84
Quantitative imaging of iodine-124 with PET. J Nucl Med (1996) 1.69
Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry (1990) 1.66
Respective roles of scatter, attenuation, depth-dependent collimator response and finite spatial resolution in cardiac single-photon emission tomography quantitation: a Monte Carlo study. Eur J Nucl Med (1999) 1.59
Evaluation of Multiclass Model Observers in PET LROC Studies. IEEE Trans Nucl Sci (2007) 1.51
Mapping cocaine binding sites in human and baboon brain in vivo. Synapse (1989) 1.29
Design and performance of POSICAM 6.5 BGO positron camera. J Nucl Med (1990) 1.18
In vivo imaging of oligonucleotides with positron emission tomography. Nat Med (1998) 1.15
PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J Nucl Med (1992) 1.10
Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol. J Cereb Blood Flow Metab (1995) 0.96
Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab (1999) 0.89
Quantitative organ time activity curve extraction from rodent PET images without anatomical prior. Med Phys (2010) 0.87
Computer-aided staging of lymphoma patients with FDG PET/CT imaging based on textural information. IEEE J Biomed Health Inform (2013) 0.87
Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J Neurosci Res (1990) 0.83
Robustness of anatomically guided pixel-by-pixel algorithms for partial volume effect correction in positron emission tomography. J Cereb Blood Flow Metab (1999) 0.83
A technique for the correction of scattered radiation in a PET system using time-of-flight information. J Comput Assist Tomogr (1986) 0.83
Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. J Cereb Blood Flow Metab (1993) 0.83
Fast nonsupervised 3D registration of PET and MR images of the brain. J Cereb Blood Flow Metab (1994) 0.82
Parametric images of benzodiazepine receptor concentration using a partial-saturation injection. J Cereb Blood Flow Metab (1997) 0.81
Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med (1993) 0.81
Characterization of neuro-endocrine tumors in an athymic nude mouse model using dedicated synchronization strategies for T2-weigted MR imaging at 7T. Conf Proc IEEE Eng Med Biol Soc (2007) 0.79
Parameter and index images of benzodiazepine receptor concentration in the brain. J Nucl Med (1995) 0.78
Quantitation of benzodiazepine receptors in human brain using the partial saturation method. J Nucl Med (1996) 0.78
Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine. Synapse (1990) 0.78
Dosimetry of transmission measurements in nuclear medicine: a study using anthropomorphic phantoms and thermoluminescent dosimeters. Eur J Nucl Med (1998) 0.78
Bromine-76-metabromobenzylguanidine: a PET radiotracer for mapping sympathetic nerves of the heart. J Nucl Med (1993) 0.78
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique. J Nucl Med (1993) 0.78
Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography. Eur J Nucl Med (1999) 0.77
Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography. Eur J Nucl Med (1999) 0.75
Synchronisation strategies in T2-weighted MR imaging for detection of liver lesions: Application on a nude mouse model. Biomed Imaging Interv J (2007) 0.75
Reaction volume concept. J Nucl Med (1997) 0.75
Positron emission tomography: basic principles and applications in psychiatric research. Ann N Y Acad Sci (1991) 0.75
Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents. Eur J Nucl Med Mol Imaging (2006) 0.75
Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidol. Synapse (1992) 0.75
Iterative crystal efficiency calculation in fully 3-D PET. IEEE Trans Med Imaging (2000) 0.75
The approximate inverse and conjugate gradient: non-symmetrical algorithms for fast attenuation correction in SPECT. Phys Med Biol (1995) 0.75
Multimodal imaging for the detection and characterization of liver lesions in a mouse model of neuroendocrine tumor. Gastroenterol Clin Biol (2008) 0.75
Comparison of clinical data sets acquired on different tomographs using 6-18F-L-dopa. Eur J Nucl Med (2000) 0.75
Validation of the three-dimensional acquisition mode in positron emission tomography for the quantitation of [18F]fluoro-DOPA uptake in the human striata. J Cereb Blood Flow Metab (1998) 0.75
Positron emission tomography instrumentation: an overview. Am J Physiol Imaging (1988) 0.75
[Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography]. Rev Pneumol Clin (1998) 0.75
Should scatter be corrected in both transmission and emission data for accurate quantitation in cardiac SPET? Eur J Nucl Med (2000) 0.75